Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Clinical trial NCT05048901 · RECRUITING
Trial details
- NCT number
- NCT05048901
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2027-08-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.